246 related articles for article (PubMed ID: 30842365)
1. The roles and role-players in thyroid cancer angiogenesis.
Rajabi S; Dehghan MH; Dastmalchi R; Jalali Mashayekhi F; Salami S; Hedayati M
Endocr J; 2019 Apr; 66(4):277-293. PubMed ID: 30842365
[TBL] [Abstract][Full Text] [Related]
2. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
3. Transcription Factor Prospero Homeobox 1 (PROX1) as a Potential Angiogenic Regulator of Follicular Thyroid Cancer Dissemination.
Rudzińska M; Mikula M; Arczewska KD; Gajda E; Sabalińska S; Stępień T; Ostrowski J; Czarnocka B
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717665
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in endocrine tumors.
Turner HE; Harris AL; Melmed S; Wass JA
Endocr Rev; 2003 Oct; 24(5):600-32. PubMed ID: 14570746
[TBL] [Abstract][Full Text] [Related]
5. Role of angiogenesis in the pathogenesis of cancer.
Hoff PM; Machado KK
Cancer Treat Rev; 2012 Nov; 38(7):825-33. PubMed ID: 22677191
[TBL] [Abstract][Full Text] [Related]
6. Effect of the micronutrient iodine in thyroid carcinoma angiogenesis.
Daniell K; Nucera C
Aging (Albany NY); 2016 Dec; 8(12):3180-3184. PubMed ID: 27997357
[TBL] [Abstract][Full Text] [Related]
7. Iodine-deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a vascular endothelial growth factor-hypoxia inducible factor-1-dependent, but not a reactive oxygen species-dependent, pathway.
Gérard AC; Humblet K; Wilvers C; Poncin S; Derradji H; de Ville de Goyet C; Abou-el-Ardat K; Baatout S; Sonveaux P; Denef JF; Colin IM
Thyroid; 2012 Jul; 22(7):699-708. PubMed ID: 22663304
[TBL] [Abstract][Full Text] [Related]
8. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in the thyroid gland.
Ramsden JD
J Endocrinol; 2000 Sep; 166(3):475-80. PubMed ID: 11029748
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases.
Jebreel A; England J; Bedford K; Murphy J; Karsai L; Atkin S
Int J Exp Pathol; 2007 Aug; 88(4):271-7. PubMed ID: 17696908
[TBL] [Abstract][Full Text] [Related]
13. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and prostate cancer tumor growth.
Nicholson B; Theodorescu D
J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
Bender RJ; Mac Gabhann F
BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
[TBL] [Abstract][Full Text] [Related]
17. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
18. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and acute myeloid leukemia.
Haouas H
Hematology; 2014 Sep; 19(6):311-23. PubMed ID: 24192539
[TBL] [Abstract][Full Text] [Related]
20. Co-regulatory potential of vascular endothelial growth factor-A and vascular endothelial growth factor-C in thyroid carcinoma.
Salajegheh A; Pakneshan S; Rahman A; Dolan-Evans E; Zhang S; Kwong E; Gopalan V; Lo CY; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2204-12. PubMed ID: 23845470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]